Table 1 Characteristic of studied group and control group
Phase II results Phase II participant characteristics Baseline characteristics for the 16 participants from Phase I who completed Phase II are shown in Table 2
2022, Aug, 17;10(1):13 Hu X, Wang J, Ju Y, Zhang X, Qimanguli W, Li C, et al
10.3389/fmed.2024.1474043 44
Ethics statement The institutional review board of Chonnam National University Hospital approved the study protocol (CNUH-EXP-2021-431)
Therefore, further clinical trials are essential to validate the precise therapeutic potential of astragaloside in obesity management, which will provide stronger support for its use in patients with arrhythmia